Newly Installed System at Apollo Hospital Treats Six and Preps Eight
Patients in First Week
SUNNYVALE, Calif., April 3 /PRNewswire-FirstCall/ -- Accuray Incorporated
(Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today
that the first patients in India have been treated using CyberKnife
radiosurgery. The CyberKnife System, which is located at the Apollo Specialty
Cancer Hospital in Chennai, India, treated six patients in its first week of
operation, with eight more patients in the treatment planning process being
readied for treatment.
"Our new CyberKnife System allows us to deliver highly precise
radiosurgical treatments to patients with tumors throughout the body," said
Prathap C. Reddy, M.D., executive chairman, Apollo Hospitals Group. "We are
very glad to have begun treating patients and look forward to witnessing the
benefits that the System offers, including real-time tracking of tumors that
move with respiration."
The CyberKnife treatment team at Apollo Hospital consists of a trained
team of highly experienced radiation oncologists, radiation therapists and a
neurosurgeon. The team plans to focus on CyberKnife radiosurgery for lung,
liver and prostate treatment as well as head, neck and spine treatments. Lung
cancer is currently one of the leading cancer incidences and causes of death
amongst men in India. (National Cancer Registry, ICMR-New Delhi)
"Since India is the second most populous nation in the world, we are
excited that CyberKnife radiosurgery is now an option for its population and
that the first patients have received treatment," said Eric P. Lindquist,
senior vice president and chief marketing officer at Accuray. "We believe this
is just the first step in the opening of a large market for the CyberKnife
System, as illustrated by the momentum within this System's first week of
use."
Advanced Medical Systems (headquartered in Singapore), the company
responsible for placing the CyberKnife at Apollo Hospital, will assist in
marketing and providing end user support for the new CyberKnife System through
its Accuray trained team of engineers and applications specialists based in
India.
About Apollo Hospitals
It was in 1983 that Dr. Prathap Reddy made a pioneering endeavor by
launching India's first corporate hospital - Apollo Hospital in Chennai. An
integrated healthcare company, the group has around 10,000 beds across 45
hospitals, more than 750 pharmacies and 100 diagnostic clinics, medical
business process outsourcing services, health insurance services, and clinical
research divisions with a focus on epidemiological studies, stem cell research
and genetic research. To develop talent for the burgeoning need of superior
healthcare delivery, the group has 10 nursing and hospital management
colleges. Harnessing technology to enhance access across India and share the
repository of knowledge, there are more than 100 telemedicine units across
seven countries. For more information, please visit: www.apollohospitals.com.
About the CyberKnife(R) Robotic Radiosurgery System
The CyberKnife Robotic Radiosurgery System is the world's only robotic
radiosurgery system designed to treat tumors anywhere in the body
non-invasively. Using continual image guidance technology and computer
controlled robotic mobility, the CyberKnife System automatically tracks,
detects and corrects for tumor and patient movement in real-time throughout
the treatment. This enables the CyberKnife System to deliver high-dose
radiation with pinpoint precision, which minimizes damage to surrounding
healthy tissue and eliminates the need for invasive head or body stabilization
frames.
About Accuray
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a
global leader in the field of radiosurgery dedicated to providing an improved
quality of life and a non-surgical treatment option for those diagnosed with
cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery
System, which extends the benefits of radiosurgery to include extracranial
tumors, including those in the spine, lung, prostate, liver and pancreas. To
date, the CyberKnife System has been used to treat more than 60,000 patients
worldwide and currently more than 155 systems have been installed in leading
hospitals in the Americas, Europe and Asia. For more information, please visit
www.accuray.com.
Safe Harbor Statement
The foregoing may contain certain forward-looking statements that involve
risks and uncertainties, including uncertainties associated with the medical
device industry. Except for the historical information contained herein, the
matters set forth in this press release, including statements relating to
commercialization of products, regulatory review and approval and clinical
studies are forward-looking statements within the meaning of the "safe harbor"
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements speak only as of the date the statements are made
and are based on information available at the time those statements are made
and/or management's good faith belief as of that time with respect to future
events. You should not put undue reliance on any forward-looking statements.
Important factors that could cause actual performance and results to differ
materially from the forward-looking statements we make include: market
acceptance of products; competing products, the combination of our products
with complementary technology; and other risks detailed from time to time
under the heading "Risk Factors" in our report on Form 10-K for the 2008
fiscal year, as updated in our Form 10-Q filed on February 5, 2009 and our
other filings with the Securities and Exchange Commission. The Company's
actual results of operations may differ significantly from those contemplated
by such forward-looking statements as a result of these and other factors. We
assume no obligation to update forward-looking statements to reflect actual
performance or results, changes in assumptions or changes in other factors
affecting forward-looking information, except to the extent required by
applicable securities laws.
SOURCE Accuray Incorporated
-0- 04/03/2009
CONTACT:
Stephanie Tomei, Senior Manager, Public Relations of Accuray
Incorporated,
+1-408-789-4234, stomei@accuray.com; or
Brianne Donahue of
Schwartz Communications,
+1-415-817-2545, bdonahue@schwartz-pr.com, for
Accuray Incorporated
Web Site: http://www.accuray.com
